Holen Sie sich die Stockscreener-App
19.32
2.99%
0.56
Vorhandelsmarkt:
20.00
0.68
+3.52%
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Pulse Biosciences Releases Nanosecond PFA Catheter Study Results - MPO-mag
Learn to Evaluate (PLSE) using the Charts - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Shares Down 7.8%Here's Why - MarketBeat
Can Pulse Biosciences' Novel Ablation Technology Disrupt Medical Device Market? Key Presentation Coming - StockTitan
Where are the Opportunities in (PLSE) - Stock Traders Daily
Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 6.6%Here's What Happened - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Hits New 12-Month HighShould You Buy? - MarketBeat
Pulse Biosciences Appoints Jon Skinner as Chief Financial Officer - Defense World
Pulse Biosciences names new CFO, continuing string of C-suite changes - MedTech Dive
Pulse Biosciences names Jon Skinner as new CFO By Investing.com - Investing.com South Africa
Pulse Biosciences names Jon Skinner as new CFO - Investing.com India
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer - BioSpace
Pulse Biosciences has a new CFO - Mass Device
Pulse Biosciences Strengthens Leadership with New CFO Appointment - TipRanks
Pulse Biosciences Names Jon Skinner CFO -February 04, 2025 at 08:54 am EST - Marketscreener.com
Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market - Nasdaq
Pulse Biosciences Names Jon Skinner Chief Financial Officer - MarketWatch
Healthcare M&A Expert Takes CFO Role at Pulse Biosciences with $5B Growth Vision - StockTitan
Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.6%Time to Buy? - MarketBeat
Griffin Asset Management Inc. Sells 19,902 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - MarketBeat
(PLSE) Technical Pivots with Risk Controls - Stock Traders Daily
Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting - BioSpace
Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences reports successful AF treatment in study - MSN
Pulse Biosciences announces presentation of late-breaking data on nsPFA 360-degree cardiac catheter system - Cardiac Rhythm News
Pulse Biosciences (NASDAQ:PLSE) Shares Up 5.2%Here's What Happened - MarketBeat
Pulse Biosciences touts positive results from PFA early feasibility study - Yahoo Finance
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium - Business Wire
Barclays PLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Barclays PLC - MarketBeat
Pulse Biosciences (NASDAQ: PLSE) Updates Investor PresentationOn January 14, 2025, Pulse Biosciences, Inc., a Delaware corporation, announced that it has posted an updated investor presentation on its website. The revised investor presentation, known - Defense World
Pulse Biosciences Updates Investors on Cardiac Innovations - TipRanks
Pulse Biosciences Appoints Paul LaViolette as CEO - TipRanks
Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium - BioSpace
Pulse Biosciences' Breakthrough nsPFA Cardiac Catheter to Headline AF Symposium 2025 - StockTitan
Jane Street Group LLC Has $233,000 Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences announces CEO appointment - MSN
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer - BioSpace
Pulse Biosciences names Paul LaViolette as CEO By Investing.com - Investing.com Canada
Pulse Biosciences names Paul LaViolette as CEO - Investing.com India
Pulse Biosciences Appoints Co-Chairman Paul LaViolette as CEO - MarketWatch
0.52%
2.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):